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Background: To examine the views and current practice of SMBG among Black Caribbean and South Asian
individuals with non-insulin treated Type 2 diabetes mellitus.
Methods: Twelve participants completed semi-structured interviews that were guided by the Health Belief Model
and analyzed using thematic network analysis.
Results: The frequency of monitoring among participants varied from several times a day to once per week. Most
participants expressed similar experiences regarding their views and practices of SMBG. Minor differences across
gender and culture were observed. All participants understood the benefits, but not all viewed SMBG as beneficial
to their personal diabetes management. SMBG can facilitate a better understanding and maintenance of self-care
behaviours. However, it can trigger both positive and negative emotional responses, such as a sense of
disappointment when high readings are not anticipated, resulting in emotional distress. Health care professionals
play a key role in the way SMBG is perceived and used by patients.
Conclusion: While the majority of participants value SMBG as a self-management tool, barriers exist that impede its
practice, particularly its cost. How individuals cope with these barriers is integral to understanding why some
patients adopt SMBG more than others.
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Self-monitoring of blood glucose (SMBG) is currently
recommended as a tool for the self-management of
Type 1 and Type 2 diabetes mellitus (DM) [1]. SMBG pro-
vides patients with information on the effect that self-
management behaviours (e.g., diet, exercise, medication)
have on blood sugar levels, which may promote better
management of these behaviours and improve glycemic
control. However, research on the effectiveness of SMBG
for non-insulin-treated patients is inconclusive and highly
debatable. Some studies have found that SMBG does not* Correspondence: egucciar@ryerson.ca
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reproduction in any medium, provided the orimprove glycemic control [2,3], while systematic literature
reviews [4-7] and meta-analyses [8-11] report a modest
improvement in glycemic control (reduction of HbA1c
from 0.21 to 0.38%) in this population. The clinical signifi-
cance of these modest improvements are questionable, as
demonstrated by a recent study utilizing the United
Kingdom Prospective Diabetes Study Outcomes Model
to forecast diabetes-related complications, quality-adjusted
life years and costs over a 40 year period [12]. Findings
indicate that the modest mean reduction of HbA1c of
0.25% [7] predicts an absolute risk reduction of dia-
betes complications by less than 1% for patients who
monitor for 40 years [12]. As a result, it has been ar-
gued that SMBG not be performed routinely by this
population [13]. Proponents of SMBG have suggestedal Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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faceted self-management program, rather than as a sole
self-management intervention [14,15].
Debate on the cost-effectiveness of SMBG also con-
tinues among researchers, healthcare professionals and
policy-makers because SMBG requires patients to pur-
chase blood glucose strips, lancets, and glucometers
[16,17]. In Canada, reimbursement of these costs varies
by province, ranging from full coverage to none [18].
Despite the uncertainty of SMBG’s clinical and cost-
effectiveness, it is important to assess patients’ views on
the utility of this practice, as they are primarily respon-
sible for their management. In fact, patients’ perspective
on SMBG practice was identified as a main knowledge
gap at a conference on SMBG held in Canada in 2006
[19]. Only two qualitative British studies [20,21], follow-
ing a white sample for 4 years, explored SMBG among
non-insulin-treated patients. These studies found that
although SMBG can increase patients’ awareness of how
self-management behaviours affect blood sugar levels, it
can also trigger feelings of anxiety, guilt, and self-blame.
In addition, health care professionals’ interest in patients’
readings had an important impact on whether patients
practice SMBG.
Given that the only research available regarding the
experiential views and practice of SMBG was conducted
in a white population, more research is needed on other
ethnic populations that share a greater burden of the
diabetes prevalence [22]. For instance, people of South
Asian or Black Caribbean ancestry [23,24], including re-
cent immigrants [25], have a disproportionately higher
prevalence of type 2 DM in Canada and worldwide;
however, they have not been well represented in the dia-
betes literature. Patients’ experiences, thoughts and
opinions about SMBG need to be accounted for and
considered in order to suitably inform clinical practice
and public policy in the treatment and management of
patients with non-insulin treated diabetes. The objective
of our study was to explore the perceived value and
practice of SMBG among South Asian and Black Carib-
bean individuals with non-insulin-treated type 2 diabetes
using the Health Belief Model [26]. Findings from this
study will contribute to the discussion on the utility of
SMBG by giving voice to populations that are dispropor-
tionately affected by diabetes.
Methods
Recruitment and sample
Participants were primarily recruited from community
health centres and diabetes education centres in the
Greater Toronto Area, in Ontario, Canada. Following
ethics approval by all recruitment sites, health care pro-
viders were asked to promote the study and provide
contact information for patients who were interested inparticipating. Participants were eligible if they had Type
2 DM and were not using insulin, were over 18 years
old, spoke English, had a history of monitoring their
blood sugar levels, and self-identified as being of Black
Caribbean or South Asian ethnicity. An honorarium was
offered to cover travel and parking costs. Through pur-
posive and snowball sampling, 12 participants were
recruited (six from each cultural group) with an equal
number of men and women. Further demographic infor-
mation is provided in Table 1.
Data collection
Semi-structured interviews were conducted in 2009 and
2010 in English by two research assistants trained in
qualitative interviewing at a location convenient for the
participant. Interviews were approximately 45 minutes
in length, were audio-recorded with participants’ con-
sent, and transcribed verbatim. Participants were asked
to complete a demographic questionnaire prior to the
interview; however, a few participants did not fully
complete it. Participants are identified by ethnicity, gen-
der and number (e.g., CW1 refers to Participant 1, who
is a Caribbean women; SAM2 refers to Participant 2,
who is a South Asian man).
The interview guide (see next paragraph) that was de-
veloped by the research team, and subsequent data ana-
lyses were based on the Health Belief Model (HBM), a
socio-psychological model that attempts to explain and
predict health behaviours [26]. The HBM assumes that a
person will take a health-related action if they: 1) feel
that a negative health condition can be avoided; 2) ex-
pect that they can avoid a negative condition with a
recommended action; and 3) believe that they can suc-
cessfully perform the recommended action. The HBM
has six major components: (a) people perceive them-
selves at risk of a health condition or complication (per-
ceived susceptibility); (b) people perceive that the health
condition or complication is serious (perceived severity);
(c) people believe that they can avoid a negative condi-
tion with a recommended action (perceived benefits); (d)
there are few self-identified psychosocial costs and bar-
riers to performing the behavior (perceived barriers);
(e) consistent stimuli within the environment promote
the recommended behaviour (cues to action); and (f )
people have confidence in their ability to successfully
perform the recommended action (self-efficacy) [26].
The HBM has been successfully used in previous dia-
betes research exploring health beliefs [27] among
various ethnic groups [28,29]. Given that SMBG is a
health-related action that can potentially help people
manage their diabetes to avoid the risk of, or delay, fur-
ther health complications, the HBM is an appropriate
conceptual model to explore the perceived value and
practice of SMBG.
Table 1 Demographic details of participants (n = 12)
Number of participants (n)
Total sample1 Black Caribbean South Asian
Mean age 56.5 (n = 10) 58 (n = 5) 55 (n = 5)
Mean years since diagnosis 6.1 (12) 7.5 (6) 4.5 (6)
Mean years living in Canada 19 (9) 32 (4) 12 (5)
Marital status (n)
Married 8 2 6
Single 2 2 0
Employment (n)
Employed 4 1 3
Part-time 2 0 2
Unemployed and looking 3 2 1
Retired 1 1 0
Education (n)
< Grade 9 1 0 1
Some High School 1 1 0
High School 2 1 1
Some post-secondary 1 1 0
Post-secondary 4 1 3
Frequency of SMBG (n)
≥ 1 time/day 7 5 2
2-4 times/week 4 1 3
1 time/week 1 0 1
1Total sample does not add up to 12 due to missing data.
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Background Information/Warm-up
 Let me start off by asking you a few question about
yourself. How long have you had diabetes?
 How do you manage your diabetes?
Perceived Severity/Susceptibility
 How serious do you think diabetes is?
 Describe how diabetes has affected you current
health.
 Describe how you think diabetes will affect your
health in the future.
 Describe what you think are your chances of
developing a diabetes complication. Why you
think that?
 How do you think monitoring your blood sugar can
affect your future health and chances of developing
complications?
Perceived Benefits of Self-monitoring
 How often do you self-monitor your blood sugar
levels?
 Tell me about your experiences with testing your
blood sugar levels.
 What do you think are the benefits of testing? Describe how testing your blood sugar either helps
or does not help you manage your diabetes.
 Describe how testing your blood sugar influences
you to perform or not perform other management
activities (such as diet, medication taking, and
exercise?)
Perceived Barriers
 Describe any difficulties you have when testing your
blood sugar.
Probes: (Stress caused by SMBG? Emotions
experienced after SMBG? How do you feel about
pricking your skin?
 Some people do not test their blood sugar regularly.
What do you think are reasons why people do not
test regularly?
 Describe what can prevent you from testing your
blood sugars regularly (What kept you from
testing?)
Probes: (Any aspect of your life? Perceived
barriers? Financial reasons? Lack of family
support?)
Cues to Action
 When you last saw your doctor, what advice were
you given about testing your blood sugar at home?
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questions your doctor asks you about your blood
sugar levels and your readings at each visit.
Probes: (Does s/he answer your questions? Is s/he
clear when talking to you about testing?)
 Describe how important you think it is to your
doctor that you test your blood sugar levels
at home.
 How does your doctor affect your testing of your
blood sugar?
 If you thought that testing blood sugars was not
important to your doctor, how would this affect
your testing of blood sugar?
Self-efficacy (Knowledge, Capability and Confidence)
 Describe what a high and low blood sugar reading
means to you.
Probes: (Examples of readings you have had?
What did you think when you got your reading?)
 Describe any actions you take to control your blood
sugar levels when you get high and low readings.
Probes: (Any lifestyle changes or behaviours?)
 Describe how confident you are in your ability to
monitor your blood sugar levels.
Probes: (Using your equipment at home?)
 How confident are you about your ability to control
you blood sugar levels within recommended the
range?
 Describe how testing your blood sugar affects your
ability to manage your diabetes.
Probes: (Does it make it easier? Harder? How so?)
 How confident are you in operating the glucometer?
 How comfortable are you with your level of
knowledge about monitoring your blood sugars?
Why do you feel that way?
 Describe any experiences you have had, if any, when
you were unsure about why you were getting certain
blood sugar readings.
Other Variables
 Please describe how testing your blood sugar may
affect other parts of your daily and family life.
Cool-Down/Wrap-up Questions
 Is there anything else I haven’t asked you about that
you would like to add?
 The responses you have provided may lead to some
more questions. If so, can we contact you for a brief
telephone interview?
Data analysis
Interview transcripts were kept in password protected
and secure hard drives at our research lab throughout all
stages of data analysis to ensure confidentiality and data
security. Following initial data collection, all identifying
information of the participants was removed and object-
ive identifiers were used on the transcripts to ensureanonymity. Interview transcripts were imported into
NVivo 8, where thematic networks analysis [30] was
used to analyze the interview data. We selected this
study technique because there is limited research that
has focused on narrative accounts of how men and
women perceive and value the use of SMBG in their dia-
betes self-management.
Our research team was composed of two academic ex-
perts in the area of diabetes (EG & EP), two research assis-
tants training in the area of nutrition (MF & AS), one
academic expert in psychosocial issues in chronic disease
(HB), and one academic expert in mental health and self-
concept of illness (EM). To facilitate dependability (analo-
gous to reliability in quantitative research), three authors
(EG, MF, AS) open coded transcripts independently,
narrowed data into more concise ideas, identified salient
quotes or recurrent phrases and discussed their analyses
at regular meetings until they reached consensus. Emer-
ging themes were organized using the HBM; thus, deduct-
ive data analysis was conducted. Any thematic patterns
specific to gender, within and across cultural groups, as
well as participants who reported divergent experiences
were noted and discussed at research team meetings. Eth-
ics approval for this research study was obtained from
Ryerson University Research Ethics Board.
Results
All participants reported that their physician had
recommended that they use SMBG, and all acknowledged
SMBG as an important tool in the general management
of diabetes. All participants had access to at least one
glucometer, and all stated they were practicing SMBG at
least once a week. Most participants had been given a
glucometer and instructed on its use by their physician or
a diabetes educator. The frequency of SMBG varied among
participants, from several times a day to once a week (see
Table 1). Most Caribbean participants practiced SMBG
once a day or more, whereas most South Asian partici-
pants practiced it once a day or less. Some participants
kept log books provided by their physician or diabetes edu-
cator, in which they recorded their blood glucose results.
Although there was variation across participants in years
since diagnosis of diabetes, diabetes symptoms, level of dia-
betes education, and treatment plan, their experiences
practicing SMBG were somewhat similar. In the following
sections, emerging themes representing participants’ per-
spectives on SMBG are organized according to the HBM
and are presented with participant quotes.
Theme one: perceived severity of diabetes and
susceptibility of future complications
All participants expressed the belief that their chances
of future diabetes-related complications are high, given
the severity of the disease. Recognizing that diabetes is
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themselves to be susceptible to complications, and all
expressed uncertainty about their future health. These
findings were evident in the fear that several participants
described regarding further complications (i.e., losing
their sight or a limb) and of possibly needing insulin in-
jections in the future.
CW3: That I’m gonna go blind, or lose one of my…
that I’ll still be able to get around. My nurse told me
that the next time I go to my doctor, ask her to send
me to an eye specialist to examine my eyes because
with the diabetes, it might be bleeding at the back of
the eyes or something so, that is scary. Especially to
think that you might lose your sight, that definitely is
scary. It’s even more scary than losing a limb, because if
I lose a foot I can still get around. So that is scary.
However, one woman participant who had been diag-
nosed with diabetes a year before the interview, had yet
to experience symptoms. Being both newly diagnosed
and asymptomatic diminished her perception of suscep-
tibility to future complications despite her awareness of
the severity of her illness and familiarity with others suf-
fering from diabetes related complications. This partici-
pant was also the least likely to practice SMBG (i.e.,
once a week) among all participants.
SAW7: …and I don’t take it [diabetes] seriously. That’s
because, as I told you, I don’t have any physical
symptoms. There was nothing much. I’m only at the
border line. Nothing’s going to happen to me. I know
it’s not true, but I keep telling myself that is not, that
nothing will happen to me. Things happen to
everybody else, but things are not going to affect me.
So it’s a false world we live in. I know I should be
taking it seriously.
Theme two: perceived benefits of SMBG
When participants were asked about the benefits of
SMBG, they all acknowledged that it is a valuable tool
for the general management of diabetes, regardless of
how often they practiced. Most used SMBG to gauge
and maintain other self-management activities, such as
diet, physical activity and taking medications that affect
their blood glucose levels.
SAM12: When you see your blood sugar is within
normal range, then you don’t feel anything. If it is
going up then you have to start thinking, what is
wrong – the type of food I’m eating yesterday or the
day before – that it is not up to the mark, or I’ve taken
some more type of carbohydrate. So then even the
knowledge – be careful, it gives you the signal. Whenyou check your blood sugar, you can see the medicine
that you are taking is of right doses, the food that
you’re taking is also the correct categories. Exercise, oh
if I miss my exercise for a day or two, it [glucose level]
remains up to 7, 7.5. The day I do my exercise for
about say 30 minutes, 20 minutes, the next morning
the blood sugar is 6.5, 6.2.
A few men expressed a strong desire to practice
SMBG as a way to understand what was physiologically
happening within their bodies. As one participant (CM4)
described, “If normally, I’m going out, I usually take it
[SMBG] to know where I stand, y’understand, it’s very
good, like, you’re gonna be out maybe for the day, it’s
very good to take it to know where you stand.” An
asymptomatic, newly diagnosed man (SAM6) conveyed
similar sentiments: “It [SMBG] is important, you know. I
just want to know it, I just want to know it, what is the
level of my blood sugar. That’s the only thing because, I
don’t feel [any symptoms] anything you know.
Other participants considered SMBG to be essential in
their daily management. For instance, one participant
(CM8) used the phrases “lifeline”, “you’re your own doc-
tor”, and “it’s like a medication, I have to bring [it every-
where]” when describing the need to perform SMBG.
Furthermore, blood glucose results within recommended
range were described as encouraging and reinforcing
self-management:
SAM12: When I see the reading is below 7, what the
doctor advised me, I feel happy. I think mentally, I’m
not worried about it. I know it [diabetes management]
is improving.
SAW11: Like, monitoring helps you. Like if it’s fine,
you can…control more. Monitoring is a check and
balance. It gives you a check. It encourages… It does
encourage me. It lets you know what it [glucose level]
is and, if it’s high.
In contrast, one participant (SAW10), despite prac-
ticing SMBG twice a week, viewed it as useless, saying
that SMBG is “just testing where you are right now.
It’s not medicine. It doesn’t motivate you do to any-
thing”. She also viewed SMBG as wasteful and costly,
particularly because she believed that she could gauge
her blood sugar highs and lows based on bodily cues
and symptoms.
Theme three: perceived barriers of SMBG
All participants identified barriers that may inhibit regu-
lar SMBG use. Five were noted most often: negative
emotional responses to unexpected blood glucose read-
ings, cost, pricking pain, burden of SMBG, and lack of
self-discipline/motivation.
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from SMBG readings. As one participant explained, “So
why would I just do it and find out, ‘Oh it’s 8 or 9’, and
then get depressed. So I wouldn’t. Why would I do it
when I know it’s high?” (SAW10). Although SMBG re-
sults encouraged individuals to reflect upon their self-
care practices, when the readings caused confusion some
participants felt frustrated and disheartened:
CW1: Sometimes I feel like giving up, I have to be
honest, I feel frustrated or dumb in spirit, you know,
at times, because, um, no matter how much I exercise
and try to eat right and I take the medication, I get
unusual readings sometimes. Because, as I said before,
for the first reading of the week it’s good, but after
each meal it just escalates. Even if I eat the right, you
know, diet or meal – follow the right meal plan, it’s
scary sometimes.
Second, the cost of lancets and strips inhibited most
participants from regular SMBG. Compared to Carib-
bean participants, South Asian participants were more
vocal about these costs:
SAW10: She [her physician] told me that you should
monitor it several times before meals, after meals,
before sleeping, getting up, to see a pattern. So, like,
the strips are very expensive… That I’m wasting this
one, this one dollar is gone. How will I be able to buy
more strips? Like, the bundle costs $100 for 100 strips.
Then I get lots of resistance from my family. My
husband will say, ‘Why are you checking it?’ I don’t
know if that is the same issue in his mind too. So,
well, it’s not a very enjoyable exercise.
A few participants reported that to reduce the cost,
they reused lancets which made lancing their skin much
more painful:
CW1: Sometimes I run out of the lancets because I
have to pay for them at the pharmacy. And, sometimes,
I have to use the same needle over and over again.
Whenever I use an old needle it pricks me harder,
y’know, it goes down deeper in my skin. It really hurts.
And I have to use the rubbing alcohol to massage it as
firmly as possible. So I try to make the sacrifice. When
I have the money, I try to make the sacrifice. Especially
this month I am buying two cases of the lancets so that
they last for the rest of the month, because sometimes
one package just lasts for a week because of the
frequency in which I have to do the testing.
Caribbean participants cited pricking pain as a barrier
more often than South Asian participants, as theytended to perform SMBG more frequently. For one par-
ticipant, pricking was the only reason he avoided SMBG
some days:
CM5: Because I’m tired of pricking my fingers. Pricking,
pricking, pricking. Sometimes I feel it so, so, you know
the nerves are right at the tips of your fingers and your
toes there, the nerves are right there, and um I could feel
it, it hurts, you know. That’s why I think sometimes, you
know, I skip couple of days, two, three days.
Fourth, two South Asian women commented on SMBG
being a “hassle”, a technical nuisance: “Besides, the ma-
chines are broken, machines, batteries they get expired.
And you don’t know how to put the batteries back in. You
have to go to a [pharmacy]. It is such a hassle” (SAW10).
Another woman emphasized the repetitive burden of
SMBG, that she feels is forced upon her, although this bur-
den did not impede regular monitoring:
SAW11: I mean if it’s high today, say 7, 7.7, 7.8, then I
see that I change my diet like that for diabetes, then I
test the next day as well. A couple of days in a row. I
mean, then it bothers you, I mean, testing in a row.
Otherwise it’s OK. And within two or three days it
comes back to around 7-ish. The idea of, I mean the
hassle of, just taking it out of the drawer – that’s, that’s
the hassle. That’s the hassle. When there is something
you have to do by force, then it’s a hassle.
Fifth, rather than identifying external sources of bar-
riers, two South Asian women internalized their barriers
and blamed themselves for not practicing SMBG regu-
larly. One (SAW7) voiced her perceived carelessness:
“No, no, it’s not the right attitude, it’s not the right thing,
I know it’s not right. I should be monitoring, I should be
taking more care of my food habits. I’m just careless
about it, I know I’m careless.” Similarly, SAW10 blamed
her lack of routine: “I’m not a very regular and organized
person, so I’m not taking advantage of it [SMBG]. I
should make a routine. I should try to be on time, check
it in the morning and then try to act accordingly”.
Theme four: cues to action
The cues to action that participants most often de-
scribed were support from physicians, family members,
and friends. First, most participants said that their physi-
cians regularly talked to them about how often to prac-
tice SMBG and gave them log books for recording their
blood sugar levels. Physicians also adjusted participants’
treatment regime when their readings were too high. In
contrast, a few participants who monitored infrequently
(SAW7 and SAW10) did not receive consistent cues for
action from their physicians, which may have affected
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couragement from physicians may be necessary to motiv-
ate SMBG practice. When there are no physician cues to
action, patients may perceive that their physicians do not
value SMBG and then perform it less often or not at all.
One participant began to doubt the value of SMBG when
her physician did not reinforce its practice:
Interviewer: Does she think it is important for you to
test?
SAW10: I don’t know. I don’t remember.
Interviewer: Do you get a sense from her?
SAW10: No, because, you know, when we see each
other, it is after many months and then for only 5–6 or
7 minutes. She quickly looks at my previous report and
then she says you are doing fine, or you are not doing
fine, you should exercise, and that’s it. If I trust the doctor,
then I wouldn’t do it [SMBG]. I would trust. He or she
knows best, so why should I do it [SMBG]? It’s [SMBG]
not a very comfortable thing, so why would I do it?
Second, most participants spoke about the prevalence
of diabetes in their families and communities. For most
participants, having family and friends with diabetes
helped them cope with diabetes management. Those
who practiced SMBG, particularly Caribbean partici-
pants, either received or sought support from family
members. However, South Asian women participants
reported that they received limited family support. As
one participant explained, her husband objected to her
testing and appears to deny that she even has diabetes:
SAW10: Like I said… I think I am mentally more busy
than I really am. Family, my husband. Family is a
demanding situation. It’s a very demanding situation…
And, so I am very careful about that. I just do [SMBG]
once in the morning sometimes. So that’s one reason.
And then I don’t have a support system from my family.
So my husband is very, very discouraging, in that he
says, ‘You say to yourself you don’t have anything’. But
he sees me doing that [SMBG], he gets so upset, he gets
really hyper – ‘You don’t have anything’ – and like that
[laughs]. So, you know, all these things, they hurt. Like
my mom tells me that ‘You should be very careful’
[about diabetes], but I don’t.
Theme five: self-efficacy
The key findings under this theme pertain to the confi-
dence participants expressed in practicing SMBG and
strategies for overcoming barriers. First, all participants
said that SMBG was easy to do and all felt confident about
their ability to use the glucometer, prick themselves and
read the results. For instance, when asked whether any-
thing could stop him from using SMBG, one participantresponded, “I don’t think anything can stop me. Even if I
travelled I can still test it” (CM8). Another said, “I try to
test my blood sugar every morning. Even if I go away for a
weekend, I take everything with me so I can test. Because
I like to know each morning what the reading is” (CW3).
A final important finding was the various strategies par-
ticipants used to overcome barriers to SMBG. These strat-
egies, which demonstrated participants’ problem-solving
skills, included reusing SMBG materials, such as lancets,
for financial reasons, and owning backup glucometers in
case one provided questionable results.
Discussion
Using the HBM, this study explored the views and prac-
tices of SMBG among Caribbean and South Asian non-
insulin-treated individuals with Type 2 DM. With the
exception of one participant, who was newly diagnosed
and the least likely to practice SMBG, most participants
believed that diabetes is a serious condition, and expressed
concern about their susceptibility to developing future
complications. Patient beliefs regarding severity and sus-
ceptibility are important, as these perceptions influence
preventative self-care behaviours [28] and observance
of self-management recommendations [31], such as
SMBG. Most participants found SMBG useful in their
daily self-management routines and were confident in
their ability to use the tool. Although all participants
practiced SMBG, the frequency varied. Most Caribbean
participants practiced SMBG more frequently, once a
day or more, compared to once a day or less for most
South Asian participants. At the time of this study,
guidelines recommended that the frequency of SMBG
should be individualized [32], resulting in physicians
and diabetes educators using professional discretion in
recommending SMBG frequency.
Participants commonly described SMBG as a feedback
tool that helps them understand and gauge the impact
of other self-management activities, such as diet, phys-
ical activity, medications, in controlling blood glucose
levels. Although this finding is consistent with the litera-
ture [20,33,34], it emphasizes the benefits that SMBG
could have in helping people modify their self-care be-
haviours. Similar to Peel et al. [24,25], some participants
described SMBG as an integral part of their diabetes
self-management that facilitated control and under-
standing of their illness. This was particularly true for
one asymptomatic participant, as testing showed him
where he “stands” physiologically. SMBG’s importance
was captured in phrases such as “lifeline”, “it’s like medi-
cation”, and as being their “duty” and “own doctor”,
demonstrating participants’ sense of responsibility in
managing the condition.
The most common barrier reported by the participants
was SMBG’s expense. This finding is well supported in
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would increase if related expenses were minimized or
eliminated [18,36]. In Ontario, the average cost per
SMBG strip is 72 cents, while in the rest of Canada, it is
almost a dollar [16]. Most of the participants in our
study were under the age of 65 and therefore not cov-
ered by the Ontario Drug Plan, which reimburses SMBG
expenses. There is mounting evidence that SMBG is not
cost-effective and many advocate that the frequency of
SMBG for patients with Type 2 DM not treated with in-
sulin should be limited (i.e., 1–2 times per week) [12,37],
which can incur a substantial reduction in expenditures
[17]. In response to this evidence, the Canadian Diabetes
Association released more specific SMBG guidelines
stating that patients who are not treated with insulin,
have stable and controlled blood glucose levels, and are
not at risk of hypoglycemia would benefit from performing
SMBG less than 2 times per week [38]. However, they
recommend a minimum government reimbursement of
30 strips per month for this group (approximately 7-8
strips per week; around 1 test per day) [1]. Given these
recent recommendations on SMBG, it is important that
healthcare professionals assess patients’ views, prefer-
ences and unique circumstances before recommending
whether and how often SMBG should be used. This
is particularly important because, as our findings re-
vealed, some participants tried to reduce the expense of
SMBG by reusing lancets, which is not a recommended
practice as it can cause more pain when pricking [39].
Our finding that SMBG can trigger both positive and
negative emotional responses, depending on the reading,
corresponds with the literature that suggests that there
is a relationship between distress and SMBG practice
among non-insulin treated individuals with diabetes
[20,21]. Readings within recommended targets encour-
aged participants such that they felt “happy” that they
are managing well. In contrast, when readings were out-
side the target range, participants feel disappointed, frus-
trated, anxious and sad. These responses are consistent
with Peel et al. [20] who found that newly diagnosed pa-
tients feel gratified when readings were low and feel like
“failures” when readings were too high. Because SMBG
may produce a sense of disappointment when readings
remain high, which can result in emotional distress,
health care providers must educate patients on the rea-
sons why SMBG readings may be inexplicable and
contradictory; for example, weight gain, new medications
or increase in medication dose, gastroparesis, illness or
infection, may all influence blood sugar levels.
We observed two South Asian women (SAW7 and
SAW10) blaming themselves for lacking the self-discipline
to practice SMBG and other diabetes self-management ac-
tivities, which was also found among women participants
in Peel et al. [20,21]. Research has shown that negativecoping strategies, such as self-blame, in diabetes manage-
ment occur more often among women than men [40],
which can potentially be explained by the lack of social sup-
port that women receive. In a meta-synthesis, Gomersall
et al. [41] report that women tend to construe diabetes self-
management as their own responsibility that needs to be
negotiated with other family members, and that the needs
of spouses and children typically take precedence over
women’s needs. We noted this contextual issue in our study
where two South Asian women expressed the demands of
family life and lack of family support in relation to SMBG.
These findings demonstrate that diabetes self-management
is influenced by multiple contexts and sociocultural factors
that are not directly under the control of the individual,
which may undermine personal agency to maintain self-
management [40]. It is important that health professionals
are aware of the gendered dimensions of diabetes self-
management and how that may differ across cultures.
The literature suggests that physicians play a crucial role
in patients’ use of SMBG [13,20,21,42]. Although most of
the participants strongly believed in the importance of
SMBG as part of diabetes management, they acknowl-
edged that physicians’ regular encouragement reinforced
their practice. Yet, one participant whose physician did
not consistently remind her to monitor, did not view
SMBG as a useful tool for diabetes management. This
finding is consistent with Peel et al.’s [20,21] findings that
patients discontinue using SMBG and view it as a waste of
time if they sense that their physicians do not value SMBG
or do not use its results to make therapeutic decisions. A
Canadian study found that healthcare providers generally
value SMBG as it allows them to identify blood-glucose
patterns that present educational opportunities for dia-
betes self-management [41]. This study also concurs with
our findings that, if healthcare professionals view SMBG
as beneficial and use its results to engage patients in dia-
logue, then patients are likely to perform SMBG [42],
highlighting the influence health care providers have in
patient views and practice of SMBG.
This study has limitations that must be noted. First,
our sample size of 12 may be considered a limitation as
it may not have allowed for data saturation. However,
many of our findings support the existing literature on
patients’ views on SMBG, which has been conducted
with white participants, and show similar themes emer-
ging from the two cultural populations represented in
this study. Nevertheless, discussions that are based on
two or less participant quotes are too preliminary to
draw strong conclusions. Another limitation is our
recruiting method, as we recruited participants from two
different cultural groups from different diabetes educa-
tion programs and health centres. These centres could
have different quality levels of patient care and services,
which in turn could have influenced study participants’
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lection bias based on centre recruitment. Also, the fact
that most participants describe SMBG as a valuable self-
management tool can potentially be due do wanting to
respond in a socially desirable manner. Finally, we did
not use ethnically matched interviewers for our study
participants, which could have facilitated in generating
more culturally specific knowledge.
Conclusion
Individuals with diabetes are major stakeholders in the
management of their condition and they should there-
fore be involved in all decisions regarding their care.
This study is the first to specifically address the perspec-
tives of ethnic minority patients’ about SMBG. Overall,
our findings show similar themes emerging from Black
Caribbean and South Asian populations compared to
the sparse literature on patients’ views on SMBG, which
predominately focused on white participants. However,
differences in self-blame and social support with regards
to the practice of SMBG were observed across gender
and culture that should be noted to better support dia-
betes self-management. Using SMBG can empower pa-
tients to better understand and maintain their diabetes
self-care behaviours. Healthcare professionals play a key
role in the way SMBG is perceived and used by patients
not on insulin. Given the financial and emotional implica-
tions of practicing SMBG, it is important for healthcare
providers to consider patients’ clinical, financial and social
context, prior to advising the use and frequency of
SMBG among non-insulin treated individuals with dia-
betes. Further research is needed to corroborate our
findings and to give voice to ethnic populations with a
disproportionate burden of diabetes on their perspec-
tive of self-management issues.
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